Stuart Rich - 11 Jun 2021 Form 4 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role: Chief Medical Officer, Director, 10%+ Owner
Signature: /s/ Stuart Rich
Issuer symbol: TENX
Transactions as of: 11 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 15 Jun 2021, 16:34:40 UTC
Next filing: 06 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TENX	Common Stock	Options Exercise		+3,581,000	+541%		4,243,517	11 Jun 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TENX	Series B Preferred Stock	Options Exercise		-3,581	-100%		0	11 Jun 2021	Common Stock	3,581,000		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On June 10, 2021, the shareholders of Tenax Therapeutics, Inc. voted in favor of the conversion of all Series B Preferred Stock to Common Stock. Pursuant to this action, all Series B Preferred Stock owned by the Reporting Person converted automatically to shares of Common Stock on June 11, 2021.
F2	As described further in Note 1, above, the disposition of the Series B Preferred Stock and the acquisition of Common Stock occurred pursuant to an automatic conversion; as such, no consideration was paid to or payable by the Reporting Person pursuant to this transaction.